Match tier Listed
Presence Current · Arkansas
Last published 2023
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Megan Shirey

Researcher

Unknown Researcher

2 h-index 2 pubs 19 cited

  • Multiple Myeloma
  • Immunoconjugates
  • Humans
  • Antibodies, Monoclonal, Humanized

Biography and Research Information

OverviewAI-generated summary

Megan Shirey's research focuses on the clinical application and effects of therapeutic agents, with a particular interest in immunoconjugates and their impact on specific diseases. Her work includes investigating the corneal toxicity associated with belantamab mafodotin, a treatment used for multiple myeloma. Shirey has also examined findings from a statewide teleretina diabetic retinopathy screening program in Arkansas, indicating an interest in the application of medical technology and screening programs for disease management.

Her scholarly output includes two publications with a total of 17 citations, and she holds an h-index of 2. Shirey collaborates with researchers at the University of Arkansas for Medical Sciences, including Sharmilan Thanendrarajan, Jaskirat Sethi, Samer Al Hadidi, and Carolina Schinke, with whom she shares publications. Her recent activity confirms her ongoing engagement in research.

Metrics

  • h-index: 2
  • Publications: 2
  • Citations: 19

Selected Publications

  • Findings from a Statewide Teleretina Diabetic Retinopathy Screening Program in Arkansas (2023)
    International Journal of Telemedicine and Applications 3 citations DOI OpenAlex
  • Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience (2022)
    American Journal of Hematology 16 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

25 Collaborators 4 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics